Peter Linsley, PhD, Director of Systems Immunology at BRI, is a trailblazer in the field of immune response regulation. On December 10, 2018, the Nobel Prize in Physiology of Medicine was awarded to two immunology researchers, James Allison, PhD, and Tasuku Honjo, PhD, for their work related to immune checkpoint inhibitors which led to the development of cancer immunotherapy. BRI celebrates Dr. Linsley’s contributions to this field of research and the understanding of the regulation of T cell activation. More